We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Biotech Researchers Encouraged to Use New Cell Line Authentication Service

By LabMedica International staff writers
Posted on 15 Aug 2011
Biotech and life science researchers working with cell cultures are now able to obtain authentication of the identity of the cells by simply mailing in a sample without even the need for dry ice.

The short tandem-repeat profiling (STR profiling) service is offered by the American Type Culture Collection or ATCC (Manassas, VA, USA). More...
STR profiling is a rapid, reproducible, and standardized PCR-based method for the unambiguous identification or authentication of human cell lines with resolution down to the individual donor. As misidentified cell lines continue to plague research, authentication of human cell lines via STR profile analysis is becoming a requirement of many journals and funding agencies.

To make it easier for researchers to document the origin of the cells they are using the ATCC offers two levels of STR profiling analysis. The Basic STR Profiling Service includes a signed Cell Line Authentication Report containing an easy-to-understand STR allele table and electropherograms that support the allele calls at each locus. The Verified STR Profiling Service includes a signed Cell Line Authentication Report containing: easy-to-understand STR allele table, electropherograms that support the allele calls at each locus, known reference profiling against the ATCC STR Profile database, and comprehensive interpretation of the results.

To take advantage of the STR profiling service the researcher first obtains an FTA Sample Collection Kit from the ATCC. The researcher simply applies cells to the FTA card following the instructions supplied with it and then sends the card to the ATCC. The need to ship samples on dry ice is eliminated.

ATCC will amplify the DNA on the card using the Promega (Madison, WI, USA) PowerPlex 16 HS System and analyze the results. Investigators can expect results via e-mail within five days from receipt of their sample at ATCC.

Related Links:

American Type Culture Collection
Promega



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers identified 157 metabolites linked to BBB damage, including 25 that appeared in at least two independent studies (Image Credit: Adobe Stock)

Blood Metabolite Patterns May Enable Early Detection of Blood-Brain Barrier Injury

Early injury to the blood-brain barrier (BBB) can precede many neurological disorders but remains difficult to detect noninvasively. Laboratory markers that identify barrier dysfunction before symptoms... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.